(Report ID: 54057) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,651 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 6 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 54057 | Feb, 24, 2006 | 72 | Female |
List of drugs the patient takes:
| Drug |
Vioxx |
Cozaar |
Pravachol |
Lasix |
Prevacid |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Acute Myocardial Infarction |
Angina Pectoris |
Chest Pain |
Coronary Artery Disease |
Coronary Artery Occlusion |
Dyspnoea Exertional |
Fatigue |
Myocardial Infarction |
Panic Attack |
Results from eHealthMe: 6 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Acute Myocardial Infarction | 5 (83.33%) |
Angina Pectoris | 5 (83.33%) |
Chest Pain | 5 (83.33%) |
Coronary Artery Disease | 5 (83.33%) |
Coronary Artery Occlusion | 1 (16.67%) |
Dyspnoea Exertional | 5 (83.33%) |
Fatigue | 5 (83.33%) |
Myocardial Infarction | 5 (83.33%) |
Panic Attack | 5 (83.33%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Fatigue | 5 (83.33%) |
2 | Myocardial Infarction | 5 (83.33%) |
3 | Coronary Artery Disease | 5 (83.33%) |
4 | Chest Pain | 5 (83.33%) |
5 | Acute Myocardial Infarction | 5 (83.33%) |
6 | Angina Pectoris | 5 (83.33%) |
7 | Panic Attack | 5 (83.33%) |
8 | Dyspnoea Exertional | 5 (83.33%) |
9 | Blood Pressure Inadequately Controlled | 3 (50.00%) |
10 | Blood Pressure | 2 (33.33%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Celebrex | 2 |
2 | Zoloft | 1 |
3 | Lexapro | 1 |
4 | Valium | 1 |
5 | Depakote | 1 |
6 | Pamelor | 1 |
7 | Zocor | 1 |
8 | Avapro | 1 |
9 | Cardizem | 1 |
10 | Hydrodiuril | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Lialda for Crohn's Disease (Nov, 21, 2008)
|
Hydrochlorothiazide (Actavis Elizabet... for Blood Pressure (Nov, 21, 2008)
|
Proscar (Merck) - 5MG for Hair Loss In Men (Nov, 21, 2008)
|
Amiodarone Hydrochloride (Alphapharm)... for Afib (Nov, 21, 2008)
|
Proscar (Merck) - 5MG for Hair Loss In Men (Nov, 21, 2008)
|
Zyrtec (Mcneil Consumer) - 10MG for Allergies (Nov, 21, 2008)
|
Allopurinol (Apotex Inc) - 300MG for Gout - Chronic (Nov, 21, 2008)
|
Nadolol for Anxiety (Nov, 21, 2008)
|
Depakote (Abbott) - EQ 500MG VALPROIC... for Epilepsy (Nov, 21, 2008)
|
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|